Management of status epilepticus in children prior to medical retrieval: Deviations from the guidelines

Preena Uppal1,2, Michael Cardamone1,2, Christopher Webber2,3,4

  • 1Department of Paediatric Neurology, Sydney Children's Hospital, Sydney, New South Wales, Australia.

Insights

Treatment guideline adherence for pediatric status epilepticus (SE) needs improvement. Excessive benzodiazepine use and delayed second-line treatments were observed, increasing the need for intubation in children with SE.

Area of Science:

  • Pediatric Emergency Medicine
  • Neurology
  • Clinical Practice Guidelines

Background:

  • Status epilepticus (SE) is a medical emergency in children requiring prompt and guideline-adherent treatment.
  • Adherence to established clinical practice guidelines for SE management can significantly impact patient outcomes.
  • The Newborn and Paediatric Emergency Transport Service (NETS) in New South Wales provides critical care for pediatric emergencies.

Purpose of the Study:

  • To assess the impact of adherence to treatment guidelines on outcomes for children with status epilepticus.
  • To evaluate management variations from the New South Wales clinical practice guideline for SE.
  • To identify areas for improvement in SE treatment protocols within a prospective registry.

Main Methods:

  • A retrospective review of children with SE treated and transported by NETS over one year.
  • Analysis of treatment variations compared to the New South Wales clinical practice guideline for SE.
  • Evaluation of medication administration timing and dosage, particularly benzodiazepines (BZD).

Main Results:

  • Excessive administration of benzodiazepines (BZD) was noted in pediatric SE cases.
  • A significant delay in administering appropriate second-line treatment for SE (median 45 minutes) was observed.
  • Receiving five or more doses of BZD was associated with significantly higher odds of requiring intubation.

Conclusions:

  • There is substantial room for improvement in clinician compliance with SE clinical practice guidelines.
  • Current management practices for pediatric SE deviate from established guidelines, potentially affecting patient outcomes.
  • Optimizing adherence to SE guidelines is crucial for reducing complications such as intubation.
Abstract

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
235
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
201
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
342
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
256
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
231
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
323